These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26364057)

  • 21. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.
    Chen K; Yang D; Li X; Sun B; Song F; Cao W; Brat DJ; Gao Z; Li H; Liang H; Zhao Y; Zheng H; Li M; Buckner J; Patterson SD; Ye X; Reinhard C; Bhathena A; Joshi D; Mischel PS; Croce CM; Wang YM; Raghavakaimal S; Li H; Lu X; Pan Y; Chang H; Ba S; Luo L; Cavenee WK; Zhang W; Hao X
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1107-12. PubMed ID: 25583476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
    Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
    Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Relationship Between Gene Mutations and the Clinicopathological Features and Prognosis of Gastric Cancer.
    Nie Z; Zeng K; Yan Q; Liu Y; Bian Y; Zhu J; Guo Z; He F; Shi H; Guo Y
    Int J Surg Pathol; 2024 May; 32(3):486-495. PubMed ID: 37545327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
    Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of next-generation sequencing in the diagnosis of gastric cancer.
    Moradi N; Ohadian Moghadam S; Heidarzadeh S
    Scand J Gastroenterol; 2022 Jul; 57(7):842-855. PubMed ID: 35293278
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
    Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
    J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a combinatorial pipeline using two somatic variant  calling  methods  for whole exome sequence data of gastric cancer.
    Kohmoto T; Masuda K; Naruto T; Tange S; Shoda K; Hamada J; Saito M; Ichikawa D; Tajima A; Otsuji E; Imoto I
    J Med Invest; 2017; 64(3.4):233-240. PubMed ID: 28954988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of recent next generation sequencing and the need for a new classification in gastric cancer.
    Businello G; Galuppini F; Fassan M
    Best Pract Res Clin Gastroenterol; 2021; 50-51():101730. PubMed ID: 33975684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway.
    Lee J; Ou SH
    Discov Med; 2013 Aug; 16(86):7-14. PubMed ID: 23911227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular classification of gastric cancer.
    Chia NY; Tan P
    Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma.
    Wang Y; Shi T; Wang X; Hu J; Yu L; Liu Q; Wu N; Liu B; Wei J
    J Transl Med; 2021 Sep; 19(1):401. PubMed ID: 34551773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
    Sabour L; Sabour M; Ghorbian S
    Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis.
    Romano C; Di Gregorio S; Pennisi MS; Tirrò E; Broggi G; Caltabiano R; Manzella L; Ruggieri M; Vigneri P; Di Cataldo A
    Mol Biol Rep; 2022 Sep; 49(9):9059-9064. PubMed ID: 35715605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma.
    Hwang I; Cho Y; Kang SY; Kim DG; Ahn S; Lee J; Kim KM
    Pathol Res Pract; 2024 Mar; 255():155063. PubMed ID: 38324965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
    Fu Y; Wu Q; Su F; Tang Y; Lin Y; Wang W; Jiang L
    Lung Cancer; 2018 Oct; 124():1-5. PubMed ID: 30268445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.
    Sykorova V; Dvorakova S; Vcelak J; Vaclavikova E; Halkova T; Kodetova D; Lastuvka P; Betka J; Vlcek P; Reboun M; Katra R; Bendlova B
    Anticancer Res; 2015 Apr; 35(4):2029-36. PubMed ID: 25862857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.
    Wang K; Yuen ST; Xu J; Lee SP; Yan HH; Shi ST; Siu HC; Deng S; Chu KM; Law S; Chan KH; Chan AS; Tsui WY; Ho SL; Chan AK; Man JL; Foglizzo V; Ng MK; Chan AS; Ching YP; Cheng GH; Xie T; Fernandez J; Li VS; Clevers H; Rejto PA; Mao M; Leung SY
    Nat Genet; 2014 Jun; 46(6):573-82. PubMed ID: 24816253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.